Menu
Menu
OUR BUSINESS
OUR BUSINESS
| Risk | Description | 2022 RANKING | 2021 RANKING | 2020 RANKING | 2019 RANKING |
|---|---|---|---|---|---|
|
1 |
Inability to attract and retain appropriately skilled people at the right place and at the right time |
 |
|
 |
|
|
2 |
Impact of adverse financial audit opinions |
 |
- |
- |
- |
|
3 |
Inability to meet all demand for all blood products |
|
|
 |
|
|
4 |
Inability to remain financially sustainable |
 |
|
|
|
|
5 |
Failure to provide and maintain stable information management systems |
 |
|
 |
|
|
6 |
Ability to maintain R&D leading to new products/new solutions and new income streams (Opportunity) |
|
|
 |
|
|
7 |
Compromised safety and quality of blood products |
 |
|
|
|
|
8 |
Uncertainty as to the impact of the National Health Insurance (NHI) implementation on SANBS’ operations |
|
|
 |
|
|
9 |
Internal and external events that may compromise the SANBS brand |
|
|
|
|
|
10 |
Non-compliance to regulatory requirements |
|
|
|
|
|
11 |
Poor procurement practices that may impact negatively on internal service delivery |
 |
 |
- |
- |
*Morphed with Financial sustainability risk in the 2021 annual integrated report
| Risk | Description | 2022 RANKING | 2021 RANKING | 2020 RANKING | 2019 RANKING |
|---|---|---|---|---|---|
|
1 |
Inability to attract and retain appropriately skilled people at the right place and at the right time |
|
|
|
|
|
2 |
Impact of adverse financial audit opinions |
|
- |
- |
- |
|
3 |
Inability to meet all demand for all blood products |
|
|
|
|
|
4 |
Inability to remain financially sustainable |
|
|
|
|
|
5 |
Failure to provide and maintain stable information management systems |
|
|
|
|
|
6 |
Ability to maintain R&D leading to new products/new solutions and new income streams (Opportunity) |
|
|
|
|
|
7 |
Compromised safety and quality of blood products |
|
|
|
|
|
8 |
Uncertainty as to the impact of the National Health Insurance (NHI) implementation on SANBS’ operations |
|
|
|
|
|
9 |
Internal and external events that may compromise the SANBS brand |
|
|
|
|
|
10 |
Non-compliance to regulatory requirements |
|
|
|
|
|
11 |
Poor procurement practices that may impact negatively on internal service delivery |
|
|
- |
- |
*Morphed with Financial sustainability risk in the 2021 annual integrated report
Risk
Description
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
High
Level of Control
Risk
Description
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
High
Level of Control
Risk
Description
Impact of adverse financial audit opinions
Y-o-Y movement 2022
Y-o-Y movement 2021
N/A
Strategic objective
Capitals
Residual Risk
High
Level of Control
Risk
Description
Impact of adverse financial audit opinions
Y-o-Y movement 2022
Y-o-Y movement 2021
N/A
Strategic objective
Capitals
Residual Risk
High
Level of Control
Risk
Description
Inability to meet all demand for all blood products
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
High
Level of Control
Risk
Description
Inability to meet all demand for all blood products
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
High
Level of Control
Risk
Description
Inability to remain financially sustainable
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Inability to remain financially sustainable
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Failure to provide and maintain stable information management systems
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Failure to provide and maintain stable information management systems
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Ability to maintain R&D leading to new products/new solutions and new income streams (Opportunity)
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Ability to maintain R&D leading to new products/new solutions and new income streams (Opportunity)
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Compromised safety and quality of blood products
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Compromised safety and quality of blood products
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Uncertainty as to the impact of the National Health Insurance (NHI) implementation on SANBS operations
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Uncertainty as to the impact of the National Health Insurance (NHI) implementation on SANBS operations
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Internal and external events that may compromise the SANBS brand
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Internal and external events that may compromise the SANBS brand
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Non-compliance with regulatory requirements
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Non-compliance with regulatory requirements
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Poor procurement practices that may impact negatively on internal service delivery
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control
Risk
Description
Poor procurement practices that may impact negatively on internal service delivery
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
Medium
Level of Control